SCHEMBL163174

SCHEMBL163174

N#CCN1CCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3922973 0.93 CHRM2 (0.58)
SCHEMBL28729222 0.91 CHRM2 (0.56)
SCHEMBL2001425 0.82
SCHEMBL1244165 0.80
SCHEMBL3988129 0.78 CHRM2 (0.47)
SCHEMBL12004137 0.78 CHRM2 (0.67)
SCHEMBL10470951 0.77 CHRM2 (0.65)
Acetonitrile SCHEMBL28164801 0.77 PIK3CD (0.50)
SCHEMBL9468715 0.77 CHRM2 (0.65)
SCHEMBL9057404 0.76 CHRM2 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009009117-A2 CHEMOENZYMATIC PROCESSES FOR PREPARATION OF LEVETIRACETAM BIOVERDANT, INC. (US) 2009-01-15 WO claimed
CN-1578925-A Photochromic light-polarizing lens for sunglasses and method for producing same SU-JIN KIM (KR) 2005-02-09 CN claimed
US-6716857-B2 1-(3-HYDROCARBYLOXYIMINO-3-(1-ALKYL-1,2,5,6-TETRAHYDROPYRID-3-YL) -ALKYLPYRROLIDIN-2-ONE DERIVATIVES; RECEPTIVITY; ANALGESICS, GLAUCOMA, PSYCHOSIS, SCHIZOPHRENIA, ANXIOLYTIC AGENTS, BIPOLAR DISORDERS; ANTIDEPRESSANTS; SLEEP DISORDERS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2004-04-06 US claimed
US-20030119880-A1 Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2003-06-26 US claimed
US-4401769-A SOFTENERS, POLYISOCYANURATES, POLYCARBODIMIDES SEALED AIR CORPORATION (US) 1983-08-30 US claimed
EP-4376912-A1 INTERMITTENT CATHETERS ConvaTec Limited (GB) 2024-06-05 EP disclosed
EP-4376909-A1 INTERMITTENT CATHETERS ConvaTec Limited (GB) 2024-06-05 EP disclosed
WO-2024052193-A1 MEDICAL DEVICES UNOMEDICAL A/S (DK) 2024-03-14 WO disclosed
WO-2024052192-A1 FLUOROPOLYMER MEDICAL DEVICES UNOMEDICAL A/S (DK) 2024-03-14 WO disclosed
CN-116621720-B Preparation method of vigabatrin 成都硕德药业有限公司 2023-10-27 CN disclosed
CN-116621720-A Preparation method of high-purity vigabatrin 成都硕德药业有限公司 2023-08-22 CN disclosed
WO-2023007131-A1 INTERMITTENT CATHETERS CONVATEC LIMITED (GB) 2023-02-02 WO disclosed
US-20070185133-A1 Aminopyrimidine compounds and methods of use AMGEN, INC. (US) 2007-08-09 US disclosed
WO-2006066172-A1 AMINOPYRIMIDINE COMPOUNDS AND METHODS OF USE AMGEN, INC. (US) 2006-06-22 WO disclosed
CN-1578925-A Photochromic light-polarizing lens for sunglasses and method for producing same SU-JIN KIM (KR) 2005-02-09 CN disclosed
US-6716857-B2 1-(3-HYDROCARBYLOXYIMINO-3-(1-ALKYL-1,2,5,6-TETRAHYDROPYRID-3-YL) -ALKYLPYRROLIDIN-2-ONE DERIVATIVES; RECEPTIVITY; ANALGESICS, GLAUCOMA, PSYCHOSIS, SCHIZOPHRENIA, ANXIOLYTIC AGENTS, BIPOLAR DISORDERS; ANTIDEPRESSANTS; SLEEP DISORDERS KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2004-04-06 US disclosed
US-20030119880-A1 Tetrahydropyridine derivatives acting on muscarinic acetylcholine receptors KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2003-06-26 US disclosed
US-5612303-A HYDROXY OR ETHERIFIED ESTERS NITTO CHEMICAL INDUSTRY CO., LTD. (JP) 1997-03-18 US disclosed
EP-0278002-A1 1-THIOCARBAMOYLMETHYLPYRROLIDINE-2-THIONE AND METHOD OF OBTAINING IT VSESOJUZNY NAUCHNO-ISSLEDOVATELSKY KHIMIKO-FARMATSEVTICHESKY INST. IMENI SERGO ORDZHONIKIDZE (VNIKHFI) (SU) 1988-08-17 EP disclosed
US-4085059-A N-METHYL-2-PYRROLIDONE BUNKER RAMO CORPORATION (US) 1978-04-18 US disclosed